Details

[Back]

ao. Univ.-Prof. Mag. Dr. Michael Wirth

T: +43-1-4277-55407

michael.wirth@univie.ac.at

Winter term 2025

321000 OV Infoveranstaltung - Pharmazie

321001 VO Steop Einführung in die pharmazeutischen Wissenschaften - B1

321034 PR Produktionsprozesse und Qualitätskontrolle in der Pharmazeutischen Technologie - B18 - (6 Kurse)

321037 VU Pharmazeutische Wissenschaften - B20

321134 PR Produktionsprozesse und Qualitätskontrolle in der Pharmazeutischen Technologie - B18 - Zusatzkurse - (2 Kurse)

322029 VU Ausgewählte Kapitel aus der pharmazeutisch-technologischen Forschung - M13

Summer term 2025

321000 OV Infoveranstaltung - Pharmazie

321033 VO Einführung in Produktionsprozesse und Qualitätskontrolle in der Pharm. Technologie - B18

321034 PR Produktionsprozesse und Qualitätskontrolle in der Pharmazeutischen Technologie - B18 - (6 Kurse)

321037 VU Pharmazeutische Wissenschaften - B20

321134 PR Produktionsprozesse und Qualitätskontrolle in der Pharmazeutischen Technologie - B18 - Zusatzkurse - (2 Kurse)

322029 VU Ausgewählte Kapitel aus der pharmazeutisch-technologischen Forschung - M13

323007 UE Experimental Methods in Drug Discovery und Preclinical Drug Development - MPS6 - (2 Courses)

Winter term 2024

321000 OV Infoveranstaltung - Pharmazie

321001 VO Steop Einführung in die pharmazeutischen Wissenschaften - B1

321034 PR Produktionsprozesse und Qualitätskontrolle in der Pharmazeutischen Technologie - B18 - (6 Kurse)

321037 VU Pharmazeutische Wissenschaften - B20

321134 PR Produktionsprozesse und Qualitätskontrolle in der Pharmazeutischen Technologie - B18 - Zusatzkurse - (2 Kurse)

322029 VU Ausgewählte Kapitel aus der pharmazeutisch-technologischen Forschung - M13

Skoll, K, Palmetzhofer, J, Lummerstorfer, M , Anzengruber, M , Gabor, F & Wirth, M 2023, 'Human serum albumin nanoparticles as a versatile vehicle for targeted delivery of antibiotics to combat bacterial infections', Nanomedicine - Nanotechnology Biology and Medicine, vol. 50, 102685. https://doi.org/10.1016/j.nano.2023.102685

Anzengruber, M, Nepustil, LM, Kurtaj, F, Tahir, A, Skoll, K , Sami, H , Wirth, M & Gabor, F 2023, 'A Versatile Brij-Linker for One-Step Preparation of Targeted Nanoparticles', Pharmaceutics, vol. 15, no. 5, 1403. https://doi.org/10.3390/pharmaceutics15051403

Gausterer, JC, Schlager, M, Ahmadi, N, Nieratschker, M, Dahm, V, Wirth, M, Arnoldner, C, Honeder, C & Gabor, F 2023, 'A Novel Preparation Technique for Human Nasal Respiratory Mucosa to Disclose Its Glycosylation Pattern for Bioadhesive Drug Delivery.', Pharmaceutics, vol. 15, no. 3, 973. https://doi.org/10.3390/pharmaceutics15030973

Anzengruber, M, Wimmer, L, Szuchar, R, Skoll, K , Wirth, M & Gabor, F 2023, 'LogP of N-acyl-gemcitabine and lectin-corona emerge as key parameters in nanoparticulate intravesical cancer therapy', European Journal of Pharmaceutics and Biopharmaceutics, vol. 180, 106330. https://doi.org/10.1016/j.ejps.2022.106330

Vater, C, Bosch, L, Mitter, A, Göls, T, Seiser, S, Heiß, E, Elbe-Buerger, A, Wirth, M , Valenta, C & Klang, V 2022, 'Lecithin-based nanoemulsions of traditional herbal wound healing agents and their effect on human skin cells', European Journal of Pharmaceutics and Biopharmaceutics, vol. 170, pp. 1-9. https://doi.org/10.1016/j.ejpb.2021.11.004

Skoll, K , Ritschka, M, Fuchs, S, Wirth, M & Gabor, F 2021, 'Characterization of sonochemically prepared human serum albumin nanocapsules using different plant oils as core component for targeted drug delivery', Ultrasonics, vol. 76, 105617. https://doi.org/10.1016/j.ultsonch.2021.105617

Hufnagel, B, Müllner, V, Hlatky, K, Guebitz, GM, Wirth, M & Gabor, F 2021, 'Chemically modified inulin for intestinal drug delivery - A new dual bioactivity concept for inflammatory bowel disease treatment.', Carbohydrate Polymers, vol. 252, 117091. https://doi.org/10.1016/j.carbpol.2020.117091

Brauner, B, Semmler, J, Rauch, D, Nokaj, M, Haiss, P, Schwarz, P , Wirth, M & Gabor, F 2020, 'Trimethoprim-Loaded PLGA Nanoparticles Grafted with WGA as Potential Intravesical Therapy of Urinary Tract Infections-Studies on Adhesion to SV-HUCs Under Varying Time, pH, and Drug-Loading Conditions', ACS Omega, vol. 5, no. 28, pp. 17377-17384. https://doi.org/10.1021/acsomega.0c01745

Gausterer, JC, Saidov, N, Ahmadi, N, Wirth, M , Reznicek, G, Arnoldner, C, Gabor, F, Honeder, C & Zhu, C 2020, 'Intratympanic application of poloxamer 407 hydrogels results in sustained N-acetylcysteine delivery to the inner ear', European Journal of Pharmaceutics and Biopharmaceutics, vol. 150, pp. 143-155. https://doi.org/10.1016/j.ejpb.2020.03.005

Vater, C, Hlawaty, V, Werdenits, P, Cichon, MA, Klang, V, Elbe-Bürger, A, Wirth, M & Valenta, C 2020, 'Effects of lecithin-based nanoemulsions on skin: Short-time cytotoxicity MTT and BrdU studies, skin penetration of surfactants and additives and the delivery of curcumin', International Journal of Pharmaceutics, vol. 580, 119209. https://doi.org/10.1016/j.ijpharm.2020.119209

Brauner, B, Schuster, C, Wirth, M & Gabor, F 2020, 'Trimethoprim-loaded microspheres prepared from low-molecular-weight PLGA as a potential drug delivery system for the treatment of urinary tract infections.', ACS Omega, vol. 5, no. 15, pp. 9013-9022. https://doi.org/10.1021/acsomega.0c00981

Brauner, B, Schwarz, P , Wirth, M & Gabor, F 2020, 'Micro vs. nano: PLGA particles loaded with trimethoprim for instillative treatment of urinary tract infections', International Journal of Pharmaceutics, vol. 579, pp. 119-158.

Vater, C, Adamovic, A, Ruttensteiner, LM, Steiner, K, Tajpara, P, Klang, V, Elbe-Bürger, A, Wirth, M & Valenta, C 2019, 'Cytotoxicity of lecithin-based nanoemulsions on human skin cells and ex vivo skin permeation: Comparison to conventional surfactant types', International Journal of Pharmaceutics, vol. 566, pp. 383-390. https://doi.org/10.1016/j.ijpharm.2019.05.078

Apfelthaler, C , Skoll, K, Ciola, R, Gabor, F & Wirth, M 2018, 'a doxorubicin loaded colloidal delivery system for the intravesical therapy of non-muscle invasive bladder cancer using wheat germ agglutinin as targeter.', European Journal of Pharmaceutical Sciences, vol. 130, pp. 177-184.

Apfelthaler, C, Gassenbauer, P, Weisse, S, Gabor, F & Wirth, M 2018, 'A lectin mediated delivery system for the intravesical treatment of bladder diseases using poly-(L)-glutamic acid as polymeric backbone', European Journal of Pharmaceutical Sciences, vol. 111, pp. 376-382.

Binder, L, Jatschka, J, Baurecht, D , Wirth, M & Valenta, C 2017, 'Novel concentrated water-in-oil emulsions based on a non-ionic silicone surfactant: appealing application properties and tuneable viscoelasticity', European Journal of Pharmaceutics and Biopharmaceutics, vol. 120, pp. 34-42. https://doi.org/10.1016/j.ejpb.2017.08.003

Apfelthaler, C , Anzengruber, M , Gabor, F & Wirth, M 2017, 'Poly - (L) - glutamic acid drug delivery system for the intravesical therapy of bladder cancer using WGA as targeting moietly', European Journal of Pharmaceutics and Biopharmaceutics, vol. 115, pp. 131-139.

Pichl, CM, Dunkl, B, Brauner, B, Gabor, F , Wirth, M & Neutsch, L 2016, 'Biomimickry of UPEC cytoinvasion: a novel concept for improved drug delivery in UTI.', Pathogens, vol. 5, no. 1, 16. https://doi.org/10.3390/pathogens5010016

Pichl, CM, Feilhauer, S, Schwaigerlehner, R-M, Gabor, F , Wirth, M & Neutsch, L 2015, 'Glycan-mediated uptake in urothelial Primary cells: Perspectives for improved intravesical drug delivery in urinary tract infections', International Journal of Pharmaceutics, vol. 495, no. 2, pp. 710-718. https://doi.org/10.1016/j.ijpharm.2015.09.017

Engleder, E, Demmerer, E, Wang, X, Honeder, C, Zhu, C, Studenik, C , Wirth, M, Christoph, A & Gabor, F 2015, 'Determination of the glycosylation-pattern of the middle ear mucosa in Guinea pigs.', International Journal of Pharmaceutics, vol. 484, no. 1-2, pp. 124-130. https://doi.org/10.1016/j.ijpharm.2015.02.056